Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BubR1 Insufficiency Drives Transcriptomic Alterations and Pathology Associated With Cardiac Aging and Heart Failure. | Aging Cell | 2025 | 40607964 | PubTator, text mining | PubMed |
| Lablab purpureus phytochemicals demonstrate potential anticancer activity as evidenced through experimental and computational analysis. | Sci Rep | 2025 | 40595080 | PubTator, text mining | PubMed |
| RNA-Seq Uncovers Association of Endocrine-Disrupting Chemicals with Hub Genes and Transcription Factors in Aggressive Prostate Cancer. | Int J Mol Sci | 2025 | 40564927 | PubTator, text mining | PubMed |
| [Genetic analysis of two fetuses with Mosaic variegated aneuploidy syndrome caused by compound heterozygous variants in BUB1B and its upstream regulatory elements and a literature Review]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 40555658 | PubTator, text mining | PubMed |
| Characterizing the Human Fetal Perimeiotic 45,X Ovary at Single-Cell Resolution. | J Endocr Soc | 2025 | 40443572 | PubTator, text mining | PubMed |
| DNA methylation-driven genes in hepatocellular carcinoma patients: insights into immune infiltration and prognostic implications. | Front Med (Lausanne) | 2025 | 40357287 | PubTator, text mining | PubMed |
| DNA damage repair-related methylated genes RRM2 and GAPDH are prognostic biomarkers associated with immunotherapy for lung adenocarcinoma. | Genet Mol Biol | 2025 | 40341308 | PubTator, text mining | PubMed |
| A bioinformatics exploration of lung adenocarcinoma identifies hub genes with prognostic significance: from data to discovery. | J Egypt Natl Canc Inst | 2025 | 40320470 | PubTator, text mining | PubMed |
| TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma. | Front Biosci (Landmark Ed) | 2025 | 40302342 | PubTator, text mining | PubMed |
| Network-Based Integrative Analysis to Identify Key Genes and Corresponding Reporter Biomolecules for Triple-Negative Breast Cancer. | Cancer Med | 2025 | 40287845 | PubTator, text mining | PubMed |
| Identification of key hub genes and potential therapeutic drugs for nasopharyngeal carcinoma: Insights into molecular mechanisms and treatment strategies. | Braz J Otorhinolaryngol | 2025 | 40286596 | PubTator, text mining | PubMed |
| Transcriptomic signatures of prostate cancer progression: a comprehensive RNA-seq study. | 3 Biotech | 2025 | 40260408 | PubTator, text mining | PubMed |
| FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. | Comput Biol Med | 2025 | 40209578 | PubTator, text mining | PubMed |
| Tissue Biomarkers for Predicting the Risk of Oral Cancer in Patients Diagnosed With Oral Leukoplakia: A Systematic Review of the Past 4 Years. | J Oral Pathol Med | 2025 | 40200649 | PubTator, text mining | PubMed |
| Discovering potential therapeutic targets in glioblastoma multiforme using a multi-omics approach. | Pathol Res Pract | 2025 | 40168776 | PubTator, text mining | PubMed |
| A chemical-genetic system to rapidly inhibit the PP2A-B56 phosphatase reveals a role at metaphase kinetochores. | Nat Commun | 2025 | 40157924 | PubTator, text mining | PubMed |
| Investigating the functional role of BUB1B in aflatoxin B1-associated hepatocarcinogenesis. | Toxicology | 2025 | 40147685 | PubTator, text mining | PubMed |
| Molecular mechanism of Mad2 conformational conversion promoted by the Mad2-interaction motif of Cdc20. | Protein Sci | 2025 | 40143766 | PubTator, text mining | PubMed |
| Comprehensive analysis of intervention and control studies for the computational identification of dengue biomarker genes. | PLoS Negl Trop Dis | 2025 | 40100920 | PubTator, text mining | PubMed |
| A Comprehensive Analysis Revealing BUB1B as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma. | Int J Mol Sci | 2025 | 40076684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=7